-
-
The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes.
-
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy.
-
Do patients with diabetes share in the reduction of cardiovascular (CV) risk factors as much as non-diabetics?
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
-
Mention obesity or the need to lose weight, and the next thing to be brought up in many discussions is exercise. Either intuitively, or because of the attention this topic receives, many believe they are not getting enough exercise.
-
Lifestyle and dietary modifications are important tools for both prevention and adjunctive treatment of hypertension, an important risk factor for cardiovascular disease, the leading cause of death for women.
-
A randomized controlled trial demonstrated that "perfect" empathy with patients results in a better immune response, reduction of symptoms, and faster recovery from a common cold.
-
This novel, large randomized controlled trial of 808 Indian children with acute dysentery, ranging in age from 6 to 59 months, assigned each subject to one of three arms of treatment for 14 days using a base of standard oral hydration formula for each group: placebo having no additives, zinc 20 mg/5 mL supplementation, or zinc 20 mg/5 mL plus copper 2 mg/5 mL supplementation.
